[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 6, 2010

Typhoid Fever in the United States and Antibiotic Choice—Reply

JAMA. 2010;303(1):34-35. doi:10.1001/jama.2009.1936

In Reply: Dr Basnyat's comments highlight many of the current challenges in antimicrobial therapy for patients with typhoid fever. Fluoroquinolones have been widely used; however, their effectiveness depends on the susceptibility of the patient's Salmonella ser Typhi isolate and the type of fluoroquinolone.1 Gatifloxacin, a higher-generation fluoroquinolone, may be an alternative to older fluoroquinolones for S Typhi strains with decreased ciprofloxacin susceptibility.

First Page Preview View Large
First page PDF preview
First page PDF preview
×